Drugs / Butang®
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01261130 Comparator | Nov 2011 → Aug 2014 | hookworm infectious disease | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Butang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01261130 ↗ |
| Modality | Vaccine | “The investigators have chosen the Butang® hepatitis B vaccine (Instituto Butantan, Sao Paulo, Brazil) as the comparator vaccine” NCT01261130 ↗ |
| Route | Intramuscular | “Vaccinations were administered via intramuscular injection on days 0, 56, and 112.” PMID 28464026 ↗ May 2017 |